Stem cell institute in wrangle over office costs

California's stem cell institute says the property management company that promised to underwrite all their office operating costs in San Francisco appears to be reneging on the deal, and they're bringing out the legal guns to make them pony up as promised.

The dispute dates back to a deal negotiated by San Francisco's mayor to give the institute a 10-year, rent-free office in San Francisco as an incentive to lure them to the Bay area. As part of that deal, Stockbridge Capital Partners allegedly promised to cover almost half a million dollars in annual office overhead for utilities, parking and so on.

Stockbridge says that it's keeping its pledge to provide rent-free space and has been working with contributors to cover costs. The institute says it wants to make sure all i's are dotted and every t is crossed before operating costs stack up.

- read the article from the San Francisco Chronicle

Suggested Articles

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.

The takeover, the first of Paul Hudson’s time as CEO, will give Sanofi an IL-2 drug it thinks can become a foundation of future cancer combinations.

A phase 1/2b test showed Roche's antibody mosunetuzumab can trigger durable responses in a significant minority of hard-to-treat NHL patients.